Herbert Tilg

Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis.

H. Tilg, G. Lippi, E. Bonora, 2019, Diabetes & metabolism.

Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis

Dan-Qin Sun, G. Fadini, G. Targher, 2023, eGastroenterology.

Heavy arch: from inflammatory bowel diseases to metabolic disorders

T. Adolph, M. Meyer, A. Jukic, 2024, Gut.

Relationship between Helicobacter pylori infection and risk of metabolic dysfunction‐associated steatotic liver disease: An updated meta‐analysis

F. Gobbi, Z. Bisoffi, Maria Giovanna Lando, 2024, Liver international : official journal of the International Association for the Study of the Liver.

Recompensation in MASLD-related cirrhosis via metabolic bariatric surgery

T. Cheung, M. Zheng, Christopher D. Byrne, 2024, Trends in Endocrinology & Metabolism.

MASLD: a systemic metabolic disorder with cardiovascular and malignant complications

G. Targher, Herbert Tilg, Christopher D Byrne, 2024, Gut.

Ferritin—a promising biomarker in MASLD

Herbert Tilg, Heinz Zoller, 2024, Gut.

Western diets and chronic diseases.

T. Adolph, Herbert Tilg, 2024, Nature medicine.

Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis

A. Csermely, Josh Bilson, Herbert Tilg, 2024, Gut.

Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link

M. Effenberger, F. Grabherr, C. Grander, 2023, Journal of clinical and translational hepatology.